N-Formylmethionine Is a Biologically Active Diagnostic Marker of Mild Traumatic Brain Injury
Study Overview This research investigates the role of N-Formylmethionine (fMet) as a potential biomarker for mild traumatic brain injury (mTBI). […]
Study Overview This research investigates the role of N-Formylmethionine (fMet) as a potential biomarker for mild traumatic brain injury (mTBI). […]
Study Overview The investigation examines the aftermath of traumatic brain injuries (TBIs) within a diverse population over a three-month span.
Study Overview This study presents a novel approach to treating severe traumatic brain injury (TBI) through a multimodal pharmacologic treatment
Background and Significance Aneurysms associated with the anterior inferior cerebellar artery (AICA) are relatively rare but carry significant risks, including
Background of Blast Exposure Blast exposure has become a significant concern in military settings, especially given the increasing frequency of
Therapeutic Efficacy of VEGFC The treatment of traumatic brain injury (TBI) has been a significant challenge in the medical field,
Study Overview This study focuses on head injuries in Iceland, specifically analyzing the data from visits to Landspitali University Hospital
Study Overview The study investigates how symptom patterns in individuals with mild traumatic brain injury (mTBI) relate to specific types
Optimal Movement Behaviours Optimal movement behaviours are pivotal in facilitating recovery from postconcussion symptoms in children and adolescents. These behaviours
Understanding Traumatic Brain Injury Severity Traumatic brain injury (TBI) manifests in varying degrees of severity, primarily classified into three categories: